Crestchem
BSE: CRSTCHM · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Crestchem's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Crestchem Limited is an Indian manufacturer specialising in the processing of agricultural derivatives into nutrition-based chemicals. The company produces lactose, maltodextrin, and dry powder-based ingredients primarily for the pharmaceutical, nutraceutical, and food supplement industries.
Business Model
The company generates revenue by adding value to agro-based raw materials through spray drying and advanced chemical processing technologies. It operates a dedicated manufacturing facility in the Mehsana district to supply high-quality excipients to the domestic market.
Growth Outlook
Growth is driven by the increasing domestic demand for specialised nutritional additives and pharmaceutical excipients. The company focuses on maintaining its niche position within the agro-chemical processing sector.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of agricultural commodities can significantly impact the company's profit margins.
- Regulatory Compliance. The company must adhere to stringent quality and safety standards required for ingredients used in infant formula and pharmaceutical products.
- Market Concentration. As a small-cap entity, the company faces risks associated with limited product diversification and reliance on specific niche segments.
- Operational Risks. Dependence on a single manufacturing facility in the Mehsana district creates vulnerability to localised disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Crestchem and 5,000+ companies — free.
Key Metrics
REVENUE
₹30 Cr
TTM · standalone
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹9.04
TTM · standalone
RETURN ON EQUITY
33.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
46.3%
TTM · standalone
P/E
14.5x
Q4 FY26 · standalone
EV/EBITDA
6.6x
Q4 FY26 · standalone
EBITDA MARGIN
13.0%
TTM · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
CrestchemCRSTCHM | ₹40 Cr | 14.60 | 10.18 | 18.1% | 13.0% | 33.5% | 46.3% | +10.3% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Q4 FY26
Financials
Crestchem
BSE: CRSTCHM · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Crestchem's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Crestchem Limited is an Indian manufacturer specialising in the processing of agricultural derivatives into nutrition-based chemicals. The company produces lactose, maltodextrin, and dry powder-based ingredients primarily for the pharmaceutical, nutraceutical, and food supplement industries.
Business Model
The company generates revenue by adding value to agro-based raw materials through spray drying and advanced chemical processing technologies. It operates a dedicated manufacturing facility in the Mehsana district to supply high-quality excipients to the domestic market.
Growth Outlook
Growth is driven by the increasing domestic demand for specialised nutritional additives and pharmaceutical excipients. The company focuses on maintaining its niche position within the agro-chemical processing sector.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of agricultural commodities can significantly impact the company's profit margins.
- Regulatory Compliance. The company must adhere to stringent quality and safety standards required for ingredients used in infant formula and pharmaceutical products.
- Market Concentration. As a small-cap entity, the company faces risks associated with limited product diversification and reliance on specific niche segments.
- Operational Risks. Dependence on a single manufacturing facility in the Mehsana district creates vulnerability to localised disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Crestchem and 5,000+ companies — free.
Key Metrics
REVENUE
₹30 Cr
TTM · standalone
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹9.04
TTM · standalone
RETURN ON EQUITY
33.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
46.3%
TTM · standalone
P/E
14.5x
Q4 FY26 · standalone
EV/EBITDA
6.6x
Q4 FY26 · standalone
EBITDA MARGIN
13.0%
TTM · standalone
Peers · Specialty Chemicals
As of Q4 FY26